Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein

Science. 1986 Jul 11;233(4760):209-12. doi: 10.1126/science.3014647.

Abstract

Mammalian cell lines have been engineered to produce a secreted form of the AIDS retrovirus envelope glycoprotein. The recombinant protein has been isolated from growth-conditioned culture media and used to immunize animals. Antibodies directed against the recombinant molecule were found to react with the envelope glycoprotein produced in virus-infected cells. Furthermore, these antibodies were able to directly inactivate the AIDS retrovirus in a neutralization assay in vitro. The expression system reported here should provide sufficient quantities of the AIDS retrovirus envelope protein for biological and vaccination studies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / immunology*
  • Animals
  • Antibodies, Viral / immunology*
  • Antigens, Viral / biosynthesis
  • Antigens, Viral / immunology*
  • Cricetinae
  • Deltaretrovirus / immunology*
  • Guinea Pigs
  • HIV Antibodies
  • HIV Antigens
  • Humans
  • Immune Sera / immunology
  • Male
  • Neutralization Tests
  • Rabbits
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / immunology
  • Viral Envelope Proteins / biosynthesis
  • Viral Envelope Proteins / immunology*
  • Viral Vaccines / immunology

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • HIV Antibodies
  • HIV Antigens
  • Immune Sera
  • Recombinant Proteins
  • Viral Envelope Proteins
  • Viral Vaccines